Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of GenioGlobeNewsWire • 11/13/25
Analysts Estimate Nyxoah SA (NYXH) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 10/29/25
Nyxoah Expands in the Middle East to Provide Wider Access to GenioZacks Investment Research • 10/02/25
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.GlobeNewsWire • 09/15/25
Nyxoah SA (NYXH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/10/25
Nyxoah Secures FDA Clearance for Genio System to Treat Sleep ApneaZacks Investment Research • 08/15/25
Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep ApneaGlobeNewsWire • 08/08/25
Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep MedicineGlobeNewsWire • 07/28/25
Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025GlobeNewsWire • 06/13/25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXHAccesswire • 05/16/25